1
|
Sridhar S, Clayton RH. Fibroblast mediated dynamics in diffusively uncoupled myocytes: a simulation study using 2-cell motifs. Sci Rep 2024; 14:4493. [PMID: 38396245 PMCID: PMC10891142 DOI: 10.1038/s41598-024-54564-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2023] [Accepted: 02/14/2024] [Indexed: 02/25/2024] Open
Abstract
In healthy hearts myocytes are typically coupled to nearest neighbours through gap junctions. Under pathological conditions such as fibrosis, or in scar tissue, or across ablation lines myocytes can uncouple from their neighbours. Electrical conduction may still occur via fibroblasts that not only couple proximal myocytes but can also couple otherwise unconnected regions. We hypothesise that such coupling can alter conduction between myocytes via introduction of delays or by initiation of premature stimuli that can potentially result in reentry or conduction blocks. To test this hypothesis we have developed several 2-cell motifs and investigated the effect of fibroblast mediated electrical coupling between uncoupled myocytes. We have identified various regimes of myocyte behaviour that depend on the strength of gap-junctional conductance, connection topology, and parameters of the myocyte and fibroblast models. These motifs are useful in developing a mechanistic understanding of long-distance coupling on myocyte dynamics and enable the characterisation of interaction between different features such as myocyte and fibroblast properties, coupling strengths and pacing period. They are computationally inexpensive and allow for incorporation of spatial effects such as conduction velocity. They provide a framework for constructing scar tissue boundaries and enable linking of cellular level interactions with scar induced arrhythmia.
Collapse
Affiliation(s)
- S Sridhar
- Department of Computer Science, University of Sheffield, Sheffield, UK.
| | - Richard H Clayton
- Department of Computer Science, University of Sheffield, Sheffield, UK
| |
Collapse
|
2
|
Richter F, Rutherford KD, Cooke AJ, Meshkati M, Eddy-Abrams V, Greene D, Kosowsky J, Park Y, Aggarwal S, Burke RJ, Chang W, Connors J, Giannone PJ, Hays T, Khattar D, Polak M, Senaldi L, Smith-Raska M, Sridhar S, Steiner L, Swanson JR, Tauber KA, Barbosa M, Guttmann KF, Turro E. A Deep Intronic PKHD1 Variant Identified by SpliceAI in a Deceased Neonate With Autosomal Recessive Polycystic Kidney Disease. Am J Kidney Dis 2024:S0272-6386(24)00010-6. [PMID: 38211685 DOI: 10.1053/j.ajkd.2023.12.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2023] [Revised: 10/09/2023] [Accepted: 11/10/2023] [Indexed: 01/13/2024]
Abstract
The etiologies of newborn deaths in neonatal intensive care units usually remain unknown, even after genetic testing. Whole-genome sequencing, combined with artificial intelligence-based methods for predicting the effects of non-coding variants, provide an avenue for resolving these deaths. Using one such method, SpliceAI, we identified a maternally inherited deep intronic PKHD1 splice variant (chr6:52030169T>C), in trans with a pathogenic missense variant (p.Thr36Met), in a newborn who died of autosomal recessive polycystic kidney disease at age 2 days. We validated the deep intronic variant's impact in maternal urine-derived cells expressing PKHD1. Reverse transcription polymerase chain reaction followed by Sanger sequencing showed that the variant causes inclusion of 147bp of the canonical intron between exons 29 and 30 of PKHD1 into the mRNA, including a premature stop codon. Allele-specific expression analysis at a heterozygous site in the mother showed that the mutant allele completely suppresses canonical splicing. In an unrelated healthy control, there was no evidence of transcripts including the novel splice junction. We returned a diagnostic report to the parents, who underwent in vitro embryo selection.
Collapse
Affiliation(s)
- Felix Richter
- Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, New York; Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, New York
| | - Kayleigh D Rutherford
- Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, New York
| | - Anisha J Cooke
- Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York
| | - Malorie Meshkati
- Division of Newborn Medicine, Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, New York
| | - Vanessa Eddy-Abrams
- Division of Newborn Medicine, Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, New York
| | - Daniel Greene
- Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, New York; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York
| | - Jordana Kosowsky
- Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York
| | - Yeaji Park
- Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York
| | - Surabhi Aggarwal
- Division of Neonatology, Department of Pediatrics, Stony Brook Children's Hospital, New York, New York
| | - Rebecca J Burke
- Department of Pediatrics, Penn State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania
| | - Weili Chang
- Department of Neonatology, Pediatrics, East Carolina University, Greenville, North Carolina
| | - Jillian Connors
- Division of Neonatology, The Children's Hospital at Montefiore, Bronx, New York
| | - Peter J Giannone
- Division of Neonatology, Department of Pediatrics, University of Kentucky, Lexington, Kentucky
| | - Thomas Hays
- Division of Neonatology, Department of Pediatrics, Columbia University Irving Medical Center, New York, New York
| | - Divya Khattar
- Division of Neonatology, Department of Pediatrics, University of Kentucky, Lexington, Kentucky
| | - Mark Polak
- Department of Pediatrics, Division of Neonatology, West Virginia University School of Medicine, Morgantown, West Virginia
| | - Liana Senaldi
- Division of Newborn Medicine, Department of Pediatrics, Weill Cornell Medicine, New York-Presbyterian Hospital, New York, New York
| | - Matthew Smith-Raska
- Division of Newborn Medicine, Department of Pediatrics, Weill Cornell Medicine, New York-Presbyterian Hospital, New York, New York
| | - Shanthy Sridhar
- Division of Neonatology, Department of Pediatrics, Stony Brook Children's Hospital, New York, New York
| | - Laurie Steiner
- Department of Pediatrics, University of Rochester, Rochester, New York
| | - Jonathan R Swanson
- Division of Neonatology, Department of Pediatrics, University of Virginia Children's Hospital, Charlottesville, Virginia
| | - Kate A Tauber
- Department of Pediatrics, Albany Medical Center, Albany, New York
| | - Mafalda Barbosa
- Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, New York; Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, New York; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York
| | - Katherine F Guttmann
- Division of Newborn Medicine, Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, New York
| | - Ernest Turro
- Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, New York; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York; Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
| |
Collapse
|
3
|
Justvig SP, Su J, Clark LM, Messina C, Sridhar S, Mintzer JP. Regional tissue oxygenation in asymptomatic neonates at high risk for neonatal abstinence syndrome and impact of non-pharmacologic interventions: A case report. J Neonatal Perinatal Med 2024; 17:137-145. [PMID: 38160367 DOI: 10.3233/npm-230099] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2024]
Abstract
BACKGROUND Improving neonatal abstinence syndrome (NAS) management is an important concern, and objective measures of its physiologic impact remain elusive. We sought to determine whether near-infrared spectroscopy (NIRS)-derived tissue oxygenation (rSO2) and fractional tissue oxygen extraction (FTOE) demonstrated physiologically plausible changes correlating with standard NAS scoring. METHODS Thirty subjects (mean 39 weeks' GA and 3 127 g BW) underwent cerebral and peripheral muscle NIRS monitoring on Days of Life (DOL) Three, Five, and Seven. We examined correlations between NAS scores and FTOE and assessed the impact of non-pharmacologic swaddling and cuddling. RESULTS No statistically significant correlations between NAS scores and FTOE were observed; however, plausible trends were demonstrated between NAS scores and cerebral measurements. Buprenorphine-exposed babies (57%) showed significantly lower FTOE when swaddled (DOL7). CONCLUSIONS Tissue oxygenation monitoring demonstrates potential to provide objective, clinically relevant physiologic information on infants at risk for NAS. Further study is required to determine whether NIRS-derived measures could assist in individualizing NAS care.
Collapse
Affiliation(s)
- S P Justvig
- Pediatrics, Boston Children's Hospital, Boston, MA, USA
| | - J Su
- General Surgery, University of Hawaii, Honolulu, HI, USA
| | - L M Clark
- Pediatrics, Stony Brook Children's, Stony Brook, NY, USA
| | - C Messina
- Renaissance School of Medicine, Stony Brook University, Stony Brook, NY, USA
| | - S Sridhar
- Pediatrics, Stony Brook Children's, Stony Brook, NY, USA
| | - J P Mintzer
- Neonatology, Mountainside Medical Center, Montclair, NJ, USA
| |
Collapse
|
4
|
Parsons HA, Blewett T, Chu X, Sridhar S, Santos K, Xiong K, Abramson VG, Patel A, Cheng J, Brufsky A, Rhoades J, Force J, Liu R, Traina TA, Carey LA, Rimawi MF, Miller KD, Stearns V, Specht J, Falkson C, Burstein HJ, Wolff AC, Winer EP, Tayob N, Krop IE, Makrigiorgos GM, Golub TR, Mayer EL, Adalsteinsson VA. Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030. Ann Oncol 2023; 34:899-906. [PMID: 37597579 PMCID: PMC10898256 DOI: 10.1016/j.annonc.2023.08.004] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2023] [Revised: 07/20/2023] [Accepted: 08/09/2023] [Indexed: 08/21/2023] Open
Abstract
BACKGROUND We aimed to examine circulating tumor DNA (ctDNA) and its association with residual cancer burden (RCB) using an ultrasensitive assay in patients with triple-negative breast cancer (TNBC) receiving neoadjuvant chemotherapy. PATIENTS AND METHODS We identified responders (RCB 0/1) and matched non-responders (RCB 2/3) from the phase II TBCRC 030 prospective study of neoadjuvant paclitaxel versus cisplatin in TNBC. We collected plasma samples at baseline, 3 weeks and 12 weeks (end of therapy). We created personalized ctDNA assays utilizing MAESTRO mutation enrichment sequencing. We explored associations between ctDNA and RCB status and disease recurrence. RESULTS Of 139 patients, 68 had complete samples and no additional neoadjuvant chemotherapy. Twenty-two were responders and 19 of those had sufficient tissue for whole-genome sequencing. We identified an additional 19 non-responders for a matched case-control analysis of 38 patients using a MAESTRO ctDNA assay tracking 319-1000 variants (median 1000 variants) to 114 plasma samples from 3 timepoints. Overall, ctDNA positivity was 100% at baseline, 79% at week 3 and 55% at week 12. Median tumor fraction (TFx) was 3.7 × 10-4 (range 7.9 × 10-7-4.9 × 10-1). TFx decreased 285-fold from baseline to week 3 in responders and 24-fold in non-responders. Week 12 ctDNA clearance correlated with RCB: clearance was observed in 10 of 11 patients with RCB 0, 3 of 8 with RCB 1, 4 of 15 with RCB 2 and 0 of 4 with RCB 3. Among six patients with known recurrence, five had persistent ctDNA at week 12. CONCLUSIONS Neoadjuvant chemotherapy for TNBC reduced ctDNA TFx by 285-fold in responders and 24-fold in non-responders. In 58% (22/38) of patients, ctDNA TFx dropped below the detection level of a commercially available test, emphasizing the need for sensitive tests. Additional studies will determine whether ctDNA-guided approaches can improve outcomes.
Collapse
Affiliation(s)
- H A Parsons
- Medical Oncology, Dana-Farber Cancer Institute, Boston; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston; Harvard Medical School, Boston.
| | - T Blewett
- Broad Institute of MIT and Harvard, Cambridge
| | - X Chu
- Data Science, Dana-Farber Cancer Institute, Boston
| | - S Sridhar
- Broad Institute of MIT and Harvard, Cambridge
| | - K Santos
- Medical Oncology, Dana-Farber Cancer Institute, Boston
| | - K Xiong
- Broad Institute of MIT and Harvard, Cambridge
| | | | - A Patel
- Medical Oncology, Dana-Farber Cancer Institute, Boston
| | - J Cheng
- Broad Institute of MIT and Harvard, Cambridge
| | - A Brufsky
- University of Pittsburgh School of Medicine, Pittsburgh
| | - J Rhoades
- Broad Institute of MIT and Harvard, Cambridge
| | | | - R Liu
- Broad Institute of MIT and Harvard, Cambridge
| | - T A Traina
- Memorial Sloan Kettering Cancer Center, New York
| | - L A Carey
- The University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill
| | - M F Rimawi
- Baylor College of Medicine Dan L. Duncan Comprehensive Cancer Center, Houston
| | - K D Miller
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
| | - V Stearns
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
| | - J Specht
- Seattle Cancer Care Alliance, Seattle
| | - C Falkson
- The University of Alabama at Birmingham, Birmingham
| | - H J Burstein
- Medical Oncology, Dana-Farber Cancer Institute, Boston; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston; Harvard Medical School, Boston
| | - A C Wolff
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
| | - E P Winer
- Medical Oncology, Dana-Farber Cancer Institute, Boston; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston; Harvard Medical School, Boston
| | - N Tayob
- Data Science, Dana-Farber Cancer Institute, Boston
| | - I E Krop
- Medical Oncology, Dana-Farber Cancer Institute, Boston; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston; Harvard Medical School, Boston
| | | | - T R Golub
- Broad Institute of MIT and Harvard, Cambridge
| | - E L Mayer
- Medical Oncology, Dana-Farber Cancer Institute, Boston; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston; Harvard Medical School, Boston.
| | | |
Collapse
|
5
|
Saint-Fleur AL, Alcalá HE, Sridhar S. Outcomes of neonates born through meconium-stained amniotic fluid pre and post 2015 NRP guideline implementation. PLoS One 2023; 18:e0289945. [PMID: 37561740 PMCID: PMC10414582 DOI: 10.1371/journal.pone.0289945] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2023] [Accepted: 07/30/2023] [Indexed: 08/12/2023] Open
Abstract
A shift in the Neonatal Resuscitation Program (NRP) guidelines occurred in 2015 from routine intubation and endotracheal suctioning of all meconium-stained non-vigorous infants towards less aggressive interventions based on response to initial resuscitation. This study aims to examine the impact of this change on outcomes of non-vigorous infants born through meconium-stained amniotic fluid at a level III academic NICU encompassing years before and after the change in guideline. This single-center retrospective study compared NICU therapies and clinical outcomes of 117 non-vigorous newborns pre-guideline implementation to 106 non-vigorous newborns post-guideline implementation. Nearly two thirds of infants in the pre-guideline cohort received endotracheal suctioning with recovery of meconium compared to less than a third of infants in the post-guideline cohort (p<0.01). Though a higher proportion of the pre-guideline cohort were admitted to the NICU for respiratory issues compared to the post-guideline cohort, the two groups did not differ significantly with regard to morbidity and therapies. Despite a marked reduction in rates of intubation and endotracheal suctioning, there is no difference in outcomes between pre-guideline implementation vs post-guideline implementation in non-vigorous meconium-stained infants, supporting the recent NRP guideline change and highlighting the benefit of expectant management.
Collapse
Affiliation(s)
- Ashley L. Saint-Fleur
- Department of Pediatrics, Stony Brook Children’s Hospital, Stony Brook, New York, United States of America
| | - Héctor E. Alcalá
- Department of Behavioral and Community Health, School of Public Health, University of Maryland, College Park, Maryland, United States of America
- Program in Oncology, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, United States of America
| | - Shanthy Sridhar
- Department of Pediatrics, Division of Neonatology, Stony Brook Children’s Hospital, Stony Brook, New York, United States of America
| |
Collapse
|
6
|
Beyer D, Sridhar S, Singh M, Nikdast J, Engel LS, Boudreaux K. BRASH syndrome: a close “BRASH” with death? Am J Med Sci 2023. [DOI: 10.1016/s0002-9629(23)00070-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
|
7
|
Abd El-Hack ME, Abdel-Moneim AME, Adegbeye M, Adewumi K, Ahamefule BC, Ahamefule CS, Alfaia C, Aly HF, Amin N, Anuwar S, Arapoglou D, Ashok Kumar N, Babayeva T, Badiale-Furlong E, Barroca MJ, Carabantes AG, Casano LM, Chauhan VS, Cheng X, Chentir I, Choo WT, Coelho D, Convey P, Čopíková J, Coronado-Reyes JA, Costa JLG, Costa M, Deprá MC, Dias RR, Dufossé L, Edoh O, Ekanem D, Elghandour MM, Eliopoulos C, El-Saadony MT, Eltanahy E, El-Tarabily KA, Esteves AF, Fagundes MB, Fajemisin AN, Faniyi T, Fernandes AS, Florença SG, Flores-Córdova MA, Fradinho P, Fuciños P, Gayen K, Gonçalves AL, González-Hernández JC, Guedes AC, Guiné RP, Herrera M, Iamtham S, Jack A, Jacob-Lopes E, Jaiswal M, Jayappriyan K, Jethani H, Kannaujiya VK, Khafagy A, Khanniri E, Khorshidian N, Komarcheuski AS, Lopes PA, Lupette J, Machado CA, Markou G, Maroneze MM, Martinez A, Martínez-Sánchez V, Martins CB, Melville L, Mesadri J, Mesalam NM, Mitterer-Daltoé ML, Montenegro Herrera CA, Mortazavian AM, Nascimento TCD, Nass PP, Neenu R, Nicoletti M, Nornberg ML, Nunes MC, Ogbonna CN, Ogbonna I, Ogbonna J, Pagels F, Pagnussatt FA, Pandey S, Pan-utai W, Pastrana LM, Pérez-Gálvez A, Pérez-Lloréns JL, Pestana J, Pires JC, Prates JA, Queiroz MI, Rahman KM, Rai A, Rai PK, Raja R, Ramírez-Mérida LG, Raymundo A, Rivas-Caceres RR, Rizk MZ, Roca M, Rodríguez-Roque MJ, Saad S, Salas-Salazar NA, Salem AZ, Salem HM, Salgado EM, Saloň I, Sánchez-Vega R, Sarkar S, Scaglioni PT, Schetinger LC, Shah M, Shams SGE, Sharma NK, Shehata AM, Singh A, Sinha RP, Soto-Caballero MC, Sridhar S, Sushytskyi L, Synytsya A, Teoh ML, Tiwari B, Tiwari S, Toniolo C, Torky A, Valdivia-Nájar CG, Vaquero MG, Vasconcellos RS, Vendruscolo RG, Vergara JJ, Vieira MV, Vigani M, Vingiani AM, Vingiani GM, Volpato JA, Wagner R, Wong CY, Wong NLW, Yousefi M, Yusoff FM, Zepka LQ. Contributors. Handbook of Food and Feed from Microalgae 2023:xv-xx. [DOI: 10.1016/b978-0-323-99196-4.09990-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 09/02/2023]
|
8
|
Paprcka S, Sridhar S, Goshayeshi A, Park E, Liu S, Flores R, Rocha L, Miles D, Lamani M, Cho S, Wang N, Guan Y, Chandrasekar S, Kushwaha R, Jafri S, Kaplan A, Stagnaro E, Seitz L, Kline J, Fernandez-Salas E. AB801 is a potent and selective AXL inhibitor that demonstrates significant anti-tumor activity in combination with standard of care therapeutics. Eur J Cancer 2022. [DOI: 10.1016/s0959-8049(22)01093-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
9
|
Miles D, Paprcka S, Foley C, Qu S, Lamani M, Paladugu S, Huang H, Tibrewal N, Chen A, Kulusich J, Garrido-Shaqfeh S, Fabila P, Sridhar S, Liu S, Swinarski D, Zhao X, Fernandez-Salas E, Green D, Jin L, Leleti M. Discovery and characterization of potent and selective AXL receptor tyrosine kinase inhibitor AB801. Eur J Cancer 2022. [DOI: 10.1016/s0959-8049(22)01074-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
10
|
Abdeljalil O, Stecca C, Lu C, Zhang H, Goluboff E, Sridhar S. 1749P Association between immune-mediated adverse events (imAEs) and outcomes in metastatic urothelial cancer (mUC) treated with durvalumab (D) alone or in combination with tremelimumab (T) in the DANUBE study. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.1827] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
11
|
Powles T, Sridhar S, Bellmunt J, Sternberg C, Grivas P, Hunter E, Dezfouli M, Salter M, Powell R, Dring A, Green J, Akoulitchev A, Amezquita R, Ching K, Pu J, Deng S, di Pietro A, Davis C. LBA74 Genomic biomarkers in peripheral blood (PB) from patients (pts) enrolled in the JAVELIN Bladder 100 trial of avelumab first-line (1L) maintenance in advanced urothelial carcinoma (aUC). Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.08.080] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
12
|
Aragon-Ching J, Grivas P, Loriot Y, Bellmunt J, Wang J, Michelon E, di Pietro A, Powles T, Sridhar S. 1760P Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (UC): Results from patients with ≥12 mo of treatment in JAVELIN Bladder 100. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.1838] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
13
|
Labidi S, N. Meti, R. Barua, Riromar J, Hansen A, Jiang D, Fallah-Rad N, Sridhar S, Ferrario C, Pezo R, Cheng S, Sacher A, Rose A. 1754P Association between body mass index (BMI) and anti-PD1/L1 immune checkpoint inhibitor (ICI) outcomes in patients with metastatic urothelial carcinoma (mUC). Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.1832] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
14
|
Chmielewski J, Chaudhry PM, Harer MW, Menon S, South AM, Chappell A, Griffin R, Askenazi D, Jetton J, Starr MC, Selewski DT, Sarkar S, Kent A, Fletcher J, Abitbol CL, DeFreitas M, Duara S, Charlton JR, Swanson JR, Guillet R, D’Angio C, Mian A, Rademacher E, Mhanna MJ, Raina R, Kumar D, Jetton JG, Brophy PD, Colaizy TT, Klein JM, Arikan AA, Rhee CJ, Goldstein SL, Nathan AT, Kupferman JC, Bhutada A, Rastogi S, Bonachea E, Ingraham S, Mahan J, Nada A, Cole FS, Davis TK, Dower J, Milner L, Smith A, Fuloria M, Reidy K, Kaskel FJ, Soranno DE, Gien J, Gist KM, Chishti AS, Hanna MH, Hingorani S, Juul S, Wong CS, Joseph C, DuPont T, Ohls R, Staples A, Rohatgi S, Sethi SK, Wazir S, Khokhar S, Perazzo S, Ray PE, Revenis M, Mammen C, Synnes A, Wintermark P, Zappitelli M, Woroniecki R, Sridhar S. Documentation of acute kidney injury at discharge from the neonatal intensive care unit and role of nephrology consultation. J Perinatol 2022; 42:930-936. [PMID: 35676535 PMCID: PMC9280854 DOI: 10.1038/s41372-022-01424-3] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/18/2022] [Revised: 04/29/2022] [Accepted: 05/27/2022] [Indexed: 11/09/2022]
Abstract
OBJECTIVE To investigate whether NICU discharge summaries documented neonatal AKI and estimate if nephrology consultation mediated this association. STUDY DESIGN Secondary analysis of AWAKEN multicenter retrospective cohort. EXPOSURES AKI severity and diagnostic criteria. OUTCOME AKI documentation on NICU discharge summaries using multivariable logistic regression to estimate associations and test for causal mediation. RESULTS Among 605 neonates with AKI, 13% had documented AKI. Those with documented AKI were more likely to have severe AKI (70.5% vs. 51%, p < 0.001) and SCr-only AKI (76.9% vs. 50.1%, p = 0.04). Nephrology consultation mediated 78.0% (95% CL 46.5-109.4%) of the total effect of AKI severity and 82.8% (95% CL 70.3-95.3%) of the total effect of AKI diagnostic criteria on documentation. CONCLUSION We report a low prevalence of AKI documentation at NICU discharge. AKI severity and SCr-only AKI increased odds of AKI documentation. Nephrology consultation mediated the associations of AKI severity and diagnostic criteria with documentation.
Collapse
Affiliation(s)
- Jennifer Chmielewski
- Department of Pediatrics, Division of Nephrology, Indiana University School of Medicine, Indianapolis, IN, USA
| | - Paulomi M. Chaudhry
- Department of Pediatrics, Division of Neonatology, Indiana University School of Medicine, Indianapolis, IN, USA
| | - Matthew W. Harer
- Department of Pediatrics, Division of Neonatology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
| | - Shina Menon
- Division of Nephrology, University of Washington and Seattle Children’s Hospital, Seattle, WA, USA
| | - Andrew M. South
- Department of Pediatrics, Section of Nephrology, Brenner Children’s, Wake Forest School of Medicine, Winston Salem, NC, USA.,Division of Public Health Sciences, Department of Epidemiology and Prevention, Wake Forest School of Medicine, Winston Salem, NC, USA
| | - Ashley Chappell
- Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA
| | - Russell Griffin
- Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA
| | - David Askenazi
- Department of Pediatrics, Division of Nephrology, University of Alabama at Birmingham, Birmingham, AL, USA
| | - Jennifer Jetton
- Division of Nephrology, Dialysis and Transplantation, Stead Family Department of Pediatrics, University of Iowa, Iowa City, IA, USA
| | - Michelle C. Starr
- Department of Pediatrics, Division of Nephrology, Indiana University School of Medicine, Indianapolis, IN, USA.,Pediatric and Adolescent Comparative Effectiveness Research, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA.,Correspondence and requests for materials should be addressed to Michelle C. Starr.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Weinberger B, Divers J, Campbell D, Ham S, Juliano C, Kurepa D, Lagamma E, Mally P, Nafday S, Nemerofsky S, Sridhar S, Williams K, Hanna N. Impact of the COVID-19 pandemic on the incidence of prematurity: critical role of gestational age and environment. Am J Obstet Gynecol 2022; 226:864-866. [PMID: 35218696 PMCID: PMC8919934 DOI: 10.1016/j.ajog.2022.02.028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2022] [Accepted: 02/21/2022] [Indexed: 11/09/2022]
Affiliation(s)
- Barry Weinberger
- Division of Neonatology, Department of Pediatrics, Cohen Children's Medical Center, Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, NY
| | - Jasmin Divers
- Division of Health Services Research, Department of Foundations of Medicine, NYU Long Island School of Medicine, Mineola, NY
| | - Deborah Campbell
- Division of Neonatology, Department of Pediatrics, Children's Hospital at Montefiore, Albert Einstein College of Medicine, Weiler Hospital, Bronx, NY
| | - Steven Ham
- Division of Neonatology, Department of Pediatrics, Cohen Children's Medical Center, Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, NY
| | - Courtney Juliano
- Division of Neonatology, Department of Pediatrics, Icahn School of Medicine at Mount Sinai Hospital, New York, NY
| | - Dalibor Kurepa
- Division of Neonatology, Department of Pediatrics, Cohen Children's Medical Center, Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, NY
| | - Edmund Lagamma
- Division of Newborn Medicine, Department of Pediatrics, Maria Fareri Children's Hospital, Westchester Medical Center, New York Medical College, Valhalla, NY
| | - Pradeep Mally
- Division of Neonatology, Department of Pediatrics, Hassenfeld Children's Hospital at NYU Langone, NYU Grossman School of Medicine, New York, NY
| | - Suhas Nafday
- Division of Neonatology, Department of Pediatrics, Children's Hospital at Montefiore-Weiler, Bronx, NY
| | - Sheri Nemerofsky
- Division of Neonatology, Department of Pediatrics, Children's Hospital at Montefiore, Albert Einstein College of Medicine, Wakefield Division, Bronx, NY
| | - Shanthy Sridhar
- Division of Neonatology, Department of Pediatrics, Stony Brook Children's Hospital, Renaissance School of Medicine at Stony Brook University, Stony Brook, NY
| | - Kim Williams
- Division of Neonatology, Department of Pediatrics, Lenox Hill Hospital, Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New York, NY
| | - Nazeeh Hanna
- Division of Neonatology, Department of Pediatrics, NYU Langone Hospital-Long Island, New York University Long Island School of Medicine, 259 First St., Mineola, NY 11501.
| |
Collapse
|
16
|
Abstract
Over-the-top (OTT) services such as Netflix, Prime Video, Disney+ Hotstar, Zee5, etc., have changed consumers’ content consumption behavior. Globalization and Digitalization have encouraged consumers to have limitless access to the Internet for information, leisure, entertainment, and social interconnectedness. The increase in the availability of high-speed Internet, the latest smartphones, and breakthroughs in technology have created great opportunities for the OTT sector, with people preferring to consume content on-the-go digitally rather than traditional media services, such as cable television. The Covid’19 pandemic has seen an increase in viewership’s and subscriptions towards these streaming platforms, with people of different age groups adapting to changing viewership trends. This study aims to understand Generation X’s behavioral shift (Age 41 to 55) towards OTT during Covid’19 in India. The literature review talks about the Generation X cohort of consumers, their behavioral habits, and attitudes towards technology. It also discusses the changing trends of online content consumption and how Covid’19 has created a spark in viewership’s towards India’s online media services. The research study aims to perform explanatory research to establish a relationship between the increase in consumption and subscriptions of OTT services in India by Generation X and the impact of Covid’19 on the same. Data will be collected from consumer’s age amongst 41 to 55 in India via survey questionnaires, and linear regression tests will be performed to test the hypotheses and establish a correlation between the dependent and independent variables.
Collapse
|
17
|
Mugundan S, Praveen P, Sridhar S, Prabu S, Lawrence Mary K, Ubaidullah M, Shaikh SF, Kanagesan S. Sol-gel synthesized barium doped TiO2 nanoparticles for solar photocatalytic application. INORG CHEM COMMUN 2022. [DOI: 10.1016/j.inoche.2022.109340] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
18
|
Sholklapper T, Creswell M, Davenport A, Sridhar S, Sokol A. Transvaginal approach to vesicocervical fistula repair. Am J Obstet Gynecol 2022. [DOI: 10.1016/j.ajog.2021.12.186] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
19
|
Sudha S, Ramprasath R, Cholan S, Gokul B, Sridhar S, Elhosiny Ali H, Shkir M. Enhanced triethylamine gas sensing and photocatalytic performance of Sn doped NiO (SNO) nanoparticles. INORG CHEM COMMUN 2022. [DOI: 10.1016/j.inoche.2021.109104] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
20
|
Madhusudanan V, Srinivas M, Nwokoye C, Murthy B, Sridhar S. HOPF- BIFURCATION ANALYSIS OF DELAYED COMPUTER VIRUS MODEL WITH HOLLING TYPE III INCIDENCE FUNCTION AND TREATMENT. Scientific African 2022. [DOI: 10.1016/j.sciaf.2022.e01125] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
21
|
Zlotta A, Ballas L, Niemierko A, Lajkosz K, Kuk C, Miranda G, Drumm M, Mari A, Thio E, Fleshner N, Kulkarni G, Chung P, Bristow R, Berlin A, Sridhar S, Feldman A, Wszolek M, Lee R, Zietman A, Shipley W, Saylor P, Daneshmand S, Efstathiou J. Propensity matched comparison of radical cystectomy with trimodality therapy for muscle invasive bladder cancer (MIBC): A multi-institutional study. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00840-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
22
|
Wettstein M, Berlin A, Pham S, Sridhar S, Chung P, Shabbir A, Van Der Kwast T, Qadri S, Li K, Liu N, Hermanns T, Kukarni G. Trimodal therapy versus radical cystectomy for T2 bladder cancer: real-world evidence from Ontario. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00846-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
23
|
Chadha M, Banzal S, Sridhar S, Goswami S, Barkate H, Suryawanshi S, Jadhav M, Brid M. Real-world Retrospective Assessment of Initiation and Effectiveness of Dual Combination Therapy with Metformin and Teneligliptin in Drug Naïve Indian Type 2 Diabetes Mellitus Patients (INITIATE). J Clin Diagn Res 2022. [DOI: 10.7860/jcdr/2022/51028.15902] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
Introduction: Diabetes Mellitus (DM) has become the leading health concern worldwide over the last few decades. But despite advances in both understanding of the pathophysiology of Type 2 Diabetes Mellitus (T2DM), and the development of new treatment strategies, current management of patients with T2DM remains suboptimal. Initial monotherapy is frequently inadequate in patients with high baseline Glycated Haemoglobin (HbA1c). Thus, initial combination therapy has emerged as an alternative approach. Aim: To assess INItiation and effecTiveness of dual combInation therapy with metformin And Teneligliptin in drug naïvE T2DM patients (INITIATE). Materials and Methods: In this retrospective, multicentre study, newly diagnosed drug naïve T2DM patients failed with diet and exercise prior to screening and initiated with dual therapy of metformin and teneligliptin were enrolled. Data of all the patients prescribed with any therapeutic dose of metformin (250 mg, 500 mg, 750 mg, 1000 mg, 1500 mg, 2000 mg) and teneligliptin (20 mg, 40 mg) was considered. The data was analysed to assess change in glycaemic parameters from baseline to 12 weeks. Paired t-test was applied for statistical results. Results: Data of 7857 patients were analysed. The mean change of Fasting Plasma Glucose (FPG) from baseline {202.29±52.2 mg/dL (11.23±2.89 mmol/L)} to 12 weeks {142.57±34.5 mg/dL (7.91±1.91 mmol/L)} was -59.72±17.7 mg/dL (-3.31±0.98 mmol/L) (p-value <0.0001). The absolute change in mean Postprandial Plasma Glucose (PPG) from baseline {(286.26±80.43 mg/dL (15.89±4.46 mmol/L)} to 12 weeks {(198.30±42.24 mg/dL (11±2.34 mmol/L)} was -87.96±38.19 mg/dL (-4.88±2.12 mmol/L) (p-value <0.0001). Mean HbA1c level was 8.11%±1% (65±10.9 mmol/mol) at baseline and decreased significantly to 7.15%±0.94% (55±10.3 mmol/mol) (p-value <0.0001) with a mean change of -0.96±0.06 (-10.5±0.7 mmol/mol) at 12 weeks. Total 42.83% (n=3365) patients achieved target HbA1c (<7%) at 12 weeks. Conclusion: Initiation of dual therapy with metformin and teneligliptin in drug naïve Indian T2DM patients significantly improved glycaemic control.
Collapse
|
24
|
Loriot Y, Vuillet M, Mamtani R, Rosenberg J, Powles T, Sonpavde G, Duran I, Lee J, Matsubara N, Vulsteke C, Castellano D, Sridhar S, Pappo H, Valderram B, Gurney H, Bedke J, Van der heijden M, Hepp Z, Petrylak D. Qualité de vie et symptômes chez les patients atteints d’un carcinome urothélial localement avancé ou métastatique précédemment traité de l’étude Ev-301 : une étude randomisée de phase 3 comparant enfortumab vedotin à la chimiothérapie. Prog Urol 2021. [DOI: 10.1016/j.purol.2021.08.112] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
25
|
Gerberich BG, Hannon BG, Hejri A, Winger EJ, Schrader Echeverri E, Nichols LM, Gersch HG, MacLeod NA, Gupta S, Read AT, Ritch MD, Sridhar S, Toothman MG, Gershon GS, Schwaner SA, Sánchez-Rodríguez G, Goyal V, Toporek AM, Feola AJ, Grossniklaus HE, Pardue MT, Ethier CR, Prausnitz MR. Transpupillary collagen photocrosslinking for targeted modulation of ocular biomechanics. Biomaterials 2021; 271:120735. [PMID: 33721571 PMCID: PMC8044034 DOI: 10.1016/j.biomaterials.2021.120735] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2020] [Revised: 02/15/2021] [Accepted: 02/21/2021] [Indexed: 12/21/2022]
Abstract
The central vision-threatening event in glaucoma is dysfunction and loss of retinal ganglion cells (RGCs), thought to be promoted by local tissue deformations. Here, we sought to reduce tissue deformation near the optic nerve head by selectively stiffening the peripapillary sclera, i.e. the scleral region immediately adjacent to the optic nerve head. Previous scleral stiffening studies to treat glaucoma or myopia have used either pan-scleral stiffening (not regionally selective) or regionally selective stiffening with limited access to the posterior globe. We present a method for selectively stiffening the peripapillary sclera using a transpupillary annular light beam to activate methylene blue administered by retrobulbar injection. Unlike prior approaches to photocrosslinking in the eye, this approach avoids the damaging effects of ultraviolet light by employing red light. This targeted photocrosslinking approach successfully stiffened the peripapillary sclera at 6 weeks post-treatment, as measured by whole globe inflation testing. Specifically, strain was reduced by 47% when comparing treated vs. untreated sclera within the same eye (n = 7, p=0.0064) and by 54% when comparing the peripapillary sclera of treated vs. untreated eyes (n = 7, p<0.0001). Post-treatment characterization of RGCs (optic nerve axon counts/density, and grading), retinal function (electroretinography), and retinal histology revealed that photocrosslinking was associated with some ocular toxicity. We conclude that a transpupillary photocrosslinking approach enables selective scleral stiffening targeted to the peripapillary region that may be useful in future treatments of glaucoma.
Collapse
Affiliation(s)
- B G Gerberich
- Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA
| | - B G Hannon
- George W. Woodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, GA, USA
| | - A Hejri
- School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, GA, USA
| | - E J Winger
- School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, GA, USA
| | - E Schrader Echeverri
- Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA
| | - L M Nichols
- School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, GA, USA
| | - H G Gersch
- Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA
| | - N A MacLeod
- Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA
| | - S Gupta
- Daniel Guggenheim School of Aerospace Engineering, Georgia Institute of Technology, Atlanta, GA, USA
| | - A T Read
- Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA
| | - M D Ritch
- Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA
| | - S Sridhar
- Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA
| | - M G Toothman
- Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA
| | - G S Gershon
- Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA
| | - S A Schwaner
- George W. Woodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, GA, USA
| | - G Sánchez-Rodríguez
- Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA
| | - V Goyal
- School of Electrical and Computer Engineering, Georgia Institute of Technology, Atlanta, GA, USA
| | - A M Toporek
- Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA
| | - A J Feola
- Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA; Center for Visual and Neurocognitive Rehabilitation, Atlanta VA Healthcare System, Decatur, GA, USA
| | - H E Grossniklaus
- Winship Cancer Institute of Emory University, Atlanta, GA, USA; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, USA
| | - M T Pardue
- Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA; Center for Visual and Neurocognitive Rehabilitation, Atlanta VA Healthcare System, Decatur, GA, USA
| | - C R Ethier
- Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA; George W. Woodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, GA, USA.
| | - M R Prausnitz
- Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA; School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, GA, USA.
| |
Collapse
|
26
|
Kumar SS, Ragunanthanan S, Ramesh D, Rajendran V, Sridhar S. Case Reports of Two Interesting Patients with Sea Snake Envenomation. J Assoc Physicians India 2020; 68:78-81. [PMID: 33247651] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
Sea Snakes have the most potent venom among snakes known to mankind and a few species are implicated in human fatalities.1 Commonest Sea snake in the Indian Sea is Enhydrina Schistosa.2 Mortality is high in spite of therapy because of multiple complications. This is a Case report of two Fishermen who were bitten by Sea Snake and developed complications.
Collapse
Affiliation(s)
- S Senthil Kumar
- Assistant Professor, Madras Medical College, Chennai, Tamil Nadu
| | | | - D Ramesh
- Assistant Professor, Madras Medical College, Chennai, Tamil Nadu
| | - V Rajendran
- Assistant Professor, Madras Medical College, Chennai, Tamil Nadu
| | - S Sridhar
- Assistant Professor, Madras Medical College, Chennai, Tamil Nadu
| |
Collapse
|
27
|
Iadonato S, Tarcha E, Bader R, Dutzar B, Eyde N, Frazier E, Jurchen D, Lance R, Loomis C, Lustig K, Ovechkina Y, Peckham D, Posakony J, Sridhar S, Xu M, Guillaudeux T. 76P Highly potent fully human anti-VISTA antibodies efficiently abrogate the interaction of this new target checkpoint inhibitor to its different putative receptors at different pH. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.10.564] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
28
|
Affiliation(s)
- Kam Lun Hon
- Department of Pediatrics and Adolescent Medicine, The Hong Kong Children's Hospital, Hong Kong.
| | - S Sridhar
- Department of Microbiology, The University of Hong Kong; Hong Kong
| |
Collapse
|
29
|
Soria F, Giordano A, Black P, Fairey A, Cookson M, Yu E, Kassouf W, Dall’Era M, Sridhar S, McGrath J, Wright J, Thorpe A, Morgan T, Daneshmand S, Holzbeierlein J, Bivalacqua T, North S, Barocas D, Lotan Y, Grivas P, Stephenson A, Shah J, van Rhijn B, Spiess P, Shariat S, Gontero P. Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer patients without hydronephrosis: results from a large multicenter cohort study. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)35401-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
30
|
Powles T, Loriot Y, Bellmunt J, Sternberg C, Sridhar S, Petrylak D, Tambaro R, Dourthe L, Alvarez-Fernandez C, Aarts M, Mu X, Ching K, Pu J, Roychoudhury S, Davis C, di Pietro A, Grivas P. 699O Avelumab first-line (1L) maintenance + best supportive care (BSC) vs BSC alone for advanced urothelial carcinoma (UC): Association between clinical outcomes and exploratory biomarkers. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.771] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
31
|
Al-Ezzi E, Alqaisi H, Iafolla M, Sridhar S, Sacher A, Fallah-Rad N, Jiang D, Catton C, Warde P, Hamilton R, Fleshner N, Zlotta A, Hansen A. 668P Clinical factors that are prognostic for survival outcomes in men with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.927] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
32
|
Somford D, Daneshmand S, Grivas P, Sridhar S, Gupta S, Bellmunt J, Sonpavde G, Fleming M, Lerner S, Loriot Y, Li A, Takkele H, Andresen C, Rearden J, Peacock Shepherd S, Schnabel M, Pal S. 799TiP PROOF 302: A randomized, double-blind, placebo-controlled, phase III trial of infigratinib as adjuvant therapy in patients with invasive urothelial carcinoma harboring susceptible FGFR3 alterations. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.2070] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
33
|
Chan KH, Sridhar S, Zhang RR, Chu H, Fung AYF, Chan G, Chan JFW, To KKW, Hung IFN, Cheng VCC, Yuen KY. Factors affecting stability and infectivity of SARS-CoV-2. J Hosp Infect 2020; 106:226-231. [PMID: 32652214 PMCID: PMC7343644 DOI: 10.1016/j.jhin.2020.07.009] [Citation(s) in RCA: 155] [Impact Index Per Article: 38.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2020] [Accepted: 07/06/2020] [Indexed: 02/09/2023]
Abstract
BACKGROUND In late 2019, a novel human coronavirus - severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) - emerged in Wuhan, China. This virus has caused a global pandemic involving more than 200 countries. SARS-CoV-2 is highly adapted to humans and readily transmits from person-to-person. AIM To investigate the infectivity of SARS-CoV-2 under various environmental and pH conditions. The efficacies of various laboratory virus inactivation methods and home disinfectants against SARS-CoV-2 were investigated. METHODS The residual virus in dried form or in solution was titrated on to Vero E6 cells on days 0, 1, 3, 5 and 7 after incubation at different temperatures. Viral viability was determined after treatment with various disinfectants and pH solutions at room temperature (20-25oC). FINDINGS SARS-CoV-2 was able to retain viability for 3-5 days in dried form or 7 days in solution at room temperature. SARS-CoV-2 could be detected under a wide range of pH conditions from pH 4 to pH 11 for several days, and for 1-2 days in stool at room temperature but lost 5 logs of infectivity. A variety of commonly used disinfectants and laboratory inactivation procedures were found to reduce viral viability effectively. CONCLUSION This study demonstrated the stability of SARS-CoV-2 on environmental surfaces, and raises the possibility of faecal-oral transmission. Commonly used fixatives, nucleic acid extraction methods and heat inactivation were found to reduce viral infectivity significantly, which could ensure hospital and laboratory safety during the SARS-CoV-2 pandemic.
Collapse
Affiliation(s)
- K-H Chan
- Department of Microbiology, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, People's Republic of China; State Key Laboratory for Emerging Infectious Diseases, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, People's Republic of China; Carol Yu Centre for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, People's Republic of China.
| | - S Sridhar
- Department of Microbiology, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, People's Republic of China; State Key Laboratory for Emerging Infectious Diseases, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, People's Republic of China; Carol Yu Centre for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, People's Republic of China
| | - R R Zhang
- Department of Microbiology, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, People's Republic of China; Department of Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, People's Republic of China
| | - H Chu
- Department of Microbiology, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, People's Republic of China; State Key Laboratory for Emerging Infectious Diseases, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, People's Republic of China; Carol Yu Centre for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, People's Republic of China
| | - A Y-F Fung
- Department of Microbiology, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, People's Republic of China
| | - G Chan
- Department of Microbiology, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, People's Republic of China
| | - J F-W Chan
- Department of Microbiology, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, People's Republic of China; State Key Laboratory for Emerging Infectious Diseases, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, People's Republic of China; Carol Yu Centre for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, People's Republic of China
| | - K K-W To
- Department of Microbiology, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, People's Republic of China; State Key Laboratory for Emerging Infectious Diseases, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, People's Republic of China; Carol Yu Centre for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, People's Republic of China
| | - I F-N Hung
- Department of Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, People's Republic of China; State Key Laboratory for Emerging Infectious Diseases, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, People's Republic of China; Carol Yu Centre for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, People's Republic of China
| | - V C-C Cheng
- Department of Microbiology, Queen Mary Hospital, Hospital Authority, Hong Kong Special Administrative Region, People's Republic of China
| | - K-Y Yuen
- Department of Microbiology, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, People's Republic of China; State Key Laboratory for Emerging Infectious Diseases, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, People's Republic of China; Carol Yu Centre for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, People's Republic of China.
| |
Collapse
|
34
|
Gravis G, Kolinsky M, Mourey L, Piulats J, Sridhar S, Romano E, Berry W, Gurney H, Retz M, Appleman L, Boegemann M, De Bono J, Joshua A, Emmenegger U, Conter H, Laguerre B, Wu H, Schloss C, Poehlein C, Yu E. KEYNOTE-365 cohort B updated results: Pembrolizumab (pembro) plus docetaxel and prednisone in abiraterone (abi) or enzalutamide (enza) pre-treated patients with metastatic castration-resistant prostate cancer (mCRPC). EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)33163-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
35
|
Cecchi F, Carrolle D, Gustavson M, Sridhar S, de los Reyes M, Thyparambil S, Bhalkikar A, Liao WL, Coats S, Hembrough T. 13P HER2 low testing in breast cancer: How to optimize detection. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.03.149] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
36
|
Mandal S, Santhi B, Sridhar S, Vinolia K, Swaminathan P. Minor fault detection of thermocouple sensor in nuclear power plants using time series analysis. ANN NUCL ENERGY 2019. [DOI: 10.1016/j.anucene.2019.07.038] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
37
|
Mandal S, Santhi B, Sridhar S, Vinolia K, Swaminathan P. Sensor fault detection in nuclear power plants using symbolic dynamic filter. ANN NUCL ENERGY 2019. [DOI: 10.1016/j.anucene.2019.07.036] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
38
|
Hansen A, Ala-leppilampi K, McKillop C, Siu L, Bedard P, Razak ARA, Spreafico A, Sridhar S, Leighl N, Butler M, Hogg D, Sacher A, Oza A, Nisenbaum R, Webster K, Cella D, Parsons J. Development of the functional assessment of cancer therapy-immune checkpoint modulator (FACT-ICM): A scale to measure quality of life in cancer patients treated with ICMs. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz253.101] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
39
|
Powles T, Balar A, Gravis G, Jones R, Ravaud A, Florence J, Grivas P, Petrylak D, Galsky M, Carles J, Sridhar S, Arkenau HT, Carroll D, DeCesare J, Mercier F, Hodgson D, Stone J, Cosaert J, Landers D. An adaptive, biomarker directed platform study in metastatic urothelial cancer (BISCAY) with durvalumab in combination with targeted therapies. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz249.001] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
40
|
Hotte S, Winquist E, Chi K, Ellard S, Sridhar S, Emmenegger U, Salim M, Iqbal N, Canil C, Kollmannsberger C, Hansen A, Lalani AKA, Gingerich J, Finch D, Cabanero M, Wyatt A, Tu D, Vera-Badillo F, Seymour L, Smoragiewicz M. CCTG IND 232: A phase II study of durvalumab with or without tremelimumab in patients with metastatic castration resistant prostate cancer (mCRPC). Ann Oncol 2019. [DOI: 10.1093/annonc/mdz394.044] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
41
|
Al-ezzi E, Veitch Z, Salah S, Van der Kwast T, Stockley T, Malone E, Sridhar S, Sacher A, Fallah-rad N, Kulkarni G, Zlotta A, Finelli A, Hansen A. Genomic characterization of non-schistosomiasis-related squamous cell carcinoma (NSR-SCC) of the urinary bladder: A retrospective study of potential prognostic and predictive biomarkers. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz249.042] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
42
|
Dierckx H, Fenton FH, Filippi S, Pumir A, Sridhar S. Editorial: Simulating Normal and Arrhythmic Dynamics: From Sub-cellular to Tissue and Organ Level. Front Phys 2019; 7:89. [PMID: 37425197 PMCID: PMC10327871 DOI: 10.3389/fphy.2019.00089] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 07/11/2023]
Affiliation(s)
- Hans Dierckx
- Department of Physics and Astronomy, Ghent University, Gent, Belgium
| | - Flavio H. Fenton
- School of Physics, Georgia Institute of Technology, Atlanta, GA, United States
| | - Simonetta Filippi
- Nonlinear Physics and Mathematical Modelling Unit, Campus Bio-Medico University, Rome, Italy
| | - Alain Pumir
- Université de Lyon, ENS de Lyon, Université Claude Bernard, CNRS, Laboratoire de Physique, Lyon, France
| | - S. Sridhar
- Robert Bosch Centre for Cyber-Physical Systems, Indian Institute of Science, Bengaluru, India
| |
Collapse
|
43
|
Ajib K, Tjong M, Lunsky I, Tan G, Nason G, Erlich A, Manjula M, Sridhar S, Fleshner N, Zlotta A, Berlin A, Chung P, Kulkarni G. Impact of neoadjuvant chemotherapy on bladder recurrences in patients managed with trimodal therapy (TMT) for muscle-invasive bladder cancer. ACTA ACUST UNITED AC 2019. [DOI: 10.1016/s1569-9056(19)31532-5] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
44
|
Sridhar S, Sebastian S, Asokan S. Temperature sensor based on multi-layer MoS 2 coated etched fiber Bragg grating. Appl Opt 2019; 58:535-539. [PMID: 30694236 DOI: 10.1364/ao.58.000535] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/05/2018] [Accepted: 12/10/2018] [Indexed: 06/09/2023]
Abstract
The development of an etched fiber Bragg grating (eFBG)-based temperature sensor with a uniform multi-layer molybdenum-di-sulphide (MoS2) coating is presented in this paper. Multi-layer MoS2 has been coated on clad etched FBG sensors by DC magnetron sputtering of molybdenum (Mo) and subsequent sulfurization. The dependence of temperature sensitivity on the coating thickness of MoS2 on eFBGs has been tested from room temperature to 100°C. It has been found that MoS2 coated clad etched FBG sensors with a coating thickness of around 10 nm exhibit a maximum temperature sensitivity of ∼95 pm/°C (almost one order higher than that of bare fiber Bragg gratings), with a resolution of ∼0.01°C obtained using an FBG interrogator with 1 pm resolution.
Collapse
|
45
|
Bernasko J, Salnave J, Sridhar S, Messina C, Combs A. 551: Does ACT between 30 and 34 weeks gestation reduce morbidity in late preterm/early term neonates? Am J Obstet Gynecol 2019. [DOI: 10.1016/j.ajog.2018.11.573] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
46
|
Sebastian S, Sridhar S, Shiva Prasad P, Asokan S. Highly sensitive fiber Bragg grating-based pressure sensor using side-hole packaging. Appl Opt 2019; 58:115-121. [PMID: 30645508 DOI: 10.1364/ao.58.000115] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/06/2018] [Accepted: 11/07/2018] [Indexed: 06/09/2023]
Abstract
In this work, an analysis of pressure response of a fiber Bragg grating (FBG) sensor in a side-hole package is presented using the finite element method. Various parameters of the side-hole packaging such as hole radius, the distance of separation between them, the radius and length of the package, and the choice of the package material are considered and optimized in order to promote maximum pressure sensitivity of the FBG sensor. This investigation on optimization of the side-hole package parameters gives rise to pressure sensitivity of nearly 105 times as compared with the bare FBG sensor, with the numerical values of 3 pm/MPa for a bare FBG sensor to ∼280,000 pm/MPa for an optimized side-hole package FBG sensor. Such high-pressure sensitivity of an FBG sensor is being reported for the very first time in this work, to the best of our knowledge, and can be considered as the initial step toward the realization of a highly sensitive hydrophone based on FBG for sensing underwater acoustic signals.
Collapse
|
47
|
Southern J, Sridhar S, Tsou CY, Hopkins S, Collier S, Nikolayevskyy V, Lozewicz S, Lalvani A, Abubakar I, Lipman M. Discordance in latent tuberculosis (TB) test results in patients with end-stage renal disease. Public Health 2018; 166:34-39. [PMID: 30439554 DOI: 10.1016/j.puhe.2018.09.023] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2018] [Revised: 09/18/2018] [Accepted: 09/25/2018] [Indexed: 11/18/2022]
Abstract
OBJECTIVES This natural experiment was designed to assess the impact of exposure to an active case of tuberculosis (TB) on a group of immunosuppressed individuals, with end-stage renal disease over an extended follow-up. STUDY DESIGN Close contacts of people with sputum smear-positive Mycobacterium tuberculosis are at high risk of infection, particularly immunosuppressed individuals. An infectious TB healthcare worker worked in a renal dialysis unit for a month before diagnosis, with 104 renal dialysis patients, was exposed for ≥8 h. METHODS Patients were informed and invited for screening 8-10 weeks postexposure. They either underwent standard two-step assessment with tuberculin skin test (TST) and QuantiFERON®-TB Gold (Cellestis GmbH; QFN) interferon-gamma release assay (IGRA) or after consent, enrolled in a study where these two tests were performed simultaneously with T-SPOT®-TB (Oxford Immunotec Ltd; TSPOT). Patients within the study were followed up for 2 years from exposure, with QFN and TSPOT repeated at months 3 and 6 from the first testing. RESULTS Of 104 exposed individuals, 75 enrolled in the study. There was a high degree of discordance among QFN, TSPOT and TST. This was seen at both the first time point and also over time in subjects who were retested. No patients had active TB at the baseline testing. None received treatment for latent TB infection. Over the following 2 years, no one developed TB disease. CONCLUSION This study suggests that there is a low risk of progression to active TB in low-incidence countries even in high-risk groups. This plus the degree of the test result discordance emphasises the complexities of managing TB in such settings as it is unclear which of these tests, if any, provides the best diagnostic accuracy.
Collapse
Affiliation(s)
- J Southern
- Public Health England, London, United Kingdom.
| | - S Sridhar
- Imperial College London, United Kingdom
| | - C-Y Tsou
- Public Health England, London, United Kingdom
| | - S Hopkins
- Royal Free London NHS Foundation Trust, United Kingdom
| | - S Collier
- Royal Free London NHS Foundation Trust, United Kingdom
| | | | - S Lozewicz
- North Middlesex University Hospital, United Kingdom
| | - A Lalvani
- Imperial College London, United Kingdom
| | - I Abubakar
- Public Health England, London, United Kingdom
| | - M Lipman
- University College London, United Kingdom
| |
Collapse
|
48
|
Marcu I, Balica A, Lemos N, Sridhar S, Gavard J, Campian E. Pelvic Neuroanatomy Knowledge Assessment and Improvement. J Minim Invasive Gynecol 2018. [DOI: 10.1016/j.jmig.2018.09.331] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
49
|
Higgs B, Morehouse C, Brohawn P, Sridhar S, Raja R, Gao G, Englert J, Ranade K. High tumor mutational burden (TMB) and PD-L1 have similar predictive utility in 2L+ NSCLC patients (pts) treated with anti-PD-L1 and anti-CTLA-4. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy269.063] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
50
|
Yenamandra VK, Shamsudheen KV, Madhumita RC, Rijith J, Ankit V, Scaria V, Sridhar S, Kabra M, Sharma VK, Sethuraman G. Autosomal recessive epidermolysis bullosa simplex: report of three cases from India. Clin Exp Dermatol 2018; 42:800-803. [PMID: 28925504 DOI: 10.1111/ced.13182] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/20/2016] [Indexed: 11/28/2022]
Affiliation(s)
- V K Yenamandra
- Departments of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, 110029, India
| | - K V Shamsudheen
- CSIR Institute of Genomics and Integrative Biology, Mathura Road, New Delhi, India.,Academy of Scientific and Innovative Research, CSIR, New Delhi, India
| | - R C Madhumita
- Departments of Pediatrics, All India Institute of Medical Sciences, New Delhi, 110029, India
| | - J Rijith
- CSIR Institute of Genomics and Integrative Biology, Mathura Road, New Delhi, India
| | - V Ankit
- CSIR Institute of Genomics and Integrative Biology, Mathura Road, New Delhi, India
| | - V Scaria
- CSIR Institute of Genomics and Integrative Biology, Mathura Road, New Delhi, India.,Academy of Scientific and Innovative Research, CSIR, New Delhi, India
| | - S Sridhar
- CSIR Institute of Genomics and Integrative Biology, Mathura Road, New Delhi, India.,Academy of Scientific and Innovative Research, CSIR, New Delhi, India
| | - M Kabra
- Departments of Pediatrics, All India Institute of Medical Sciences, New Delhi, 110029, India
| | - V K Sharma
- Departments of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, 110029, India
| | - G Sethuraman
- Departments of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, 110029, India
| |
Collapse
|